Related Experiment Video
Updated: Jul 24, 2025
11:00
Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
Published on: December 16, 2016
7.3K
TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia
Xinyu Tang1, Ruirong Xu2,3,4, Yan Wang5,6,7
1Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
Molecular Medicine (Cambridge, Mass.)
|July 9, 2023
Summary
TERC gene haploinsufficiency impacts telomere length, potentially causing aplastic anemia. Cell reprogramming may reverse this, offering new diagnostic and therapeutic approaches for aplastic anemia patients.
Area of Science:
- Genetics and Molecular Biology
- Stem Cell Biology
- Hematology
Background:
- The telomerase RNA component (TERC) gene is crucial for telomere maintenance.
- TERC haploinsufficiency can lead to shortened telomeres and diseases like aplastic anemia (AA).
- Cell reprogramming can restore pluripotency and extend telomere length.
Purpose of the Study:
- To investigate the impact of TERC haploid cell reprogramming on telomere length.
- To explore the correlation between altered telomere length and aplastic anemia pathogenesis.
- To identify potential diagnostic markers and therapeutic strategies for AA.
Main Methods:
- Literature review and summary of studies on TERC gene function.
- Analysis of cell reprogramming techniques and their effect on telomere length.
- Correlation analysis between telomere length changes and AA development.
Main Results:
- TERC haploinsufficiency is linked to telomere shortening and aplastic anemia.
- Cell reprogramming demonstrates potential in extending telomere length.
- Altered telomere length is associated with the pathogenesis of AA.
Conclusions:
- Cell reprogramming shows promise for treating telomere-related diseases like AA.
- Further research into TERC and cell reprogramming could yield novel diagnostic and therapeutic tools for AA.
- Understanding telomere dynamics is key to managing aplastic anemia.
Related Concept Videos
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
01:14Introduction to Nuclear Reprogramming
2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K
01:13Induced Pluripotent Stem Cells
24.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.2K
01:32Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K